Litcius/Paper detail

Targeting CXCL12-CXCR4 Signaling Enhances Immune Checkpoint Blockade Therapy Against Triple Negative Breast Cancer

Guowen Lu, Yier Qiu, Xiaobao Su

2020European Journal of Pharmaceutical Sciences30 citationsDOI

Topics & Concepts

Tumor microenvironmentTriple-negative breast cancerCancer researchImmune systemMedicineStromal cellImmune checkpointBreast cancerCXCR4Chemokine receptorImmunotherapyCancerPharmacologyImmunologyChemokineInternal medicineImmunotherapy and Immune ResponsesChemokine receptors and signalingNanoplatforms for cancer theranostics
Targeting CXCL12-CXCR4 Signaling Enhances Immune Checkpoint Blockade Therapy Against Triple Negative Breast Cancer | Litcius